Cargando…
利妥昔单抗联合短周期、高强度方案治疗Burkitt白血病疗效及安全性分析
OBJECTIVE: This study aimed to explore the efficacy and safety of rituximab combined with short-course and intensive regimens in the treatment of adult patients with Burkitt leukemia. METHODS: The clinical data of 11 Burkitt leukemia patients in our hospital from January 30, 2006, to September 12, 2...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Editorial office of Chinese Journal of Hematology
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7378285/ https://www.ncbi.nlm.nih.gov/pubmed/32654465 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2020.06.012 |
Ejemplares similares
-
利妥昔单抗联合二线方案治疗七例复发难治性霍奇金淋巴瘤患者疗效观察
Publicado: (2015) -
剂量调整的EP(D)OCH方案联合利妥昔单抗治疗新诊断双表达淋巴瘤的疗效分析
Publicado: (2017) -
含利妥昔单抗联合方案治疗难治/复发血栓性血小板减少性紫癜10例临床分析
Publicado: (2018) -
凝血酶原复合物联合小剂量利妥昔单抗治疗血友病B伴抑制物
Publicado: (2017) -
BTK抑制剂、维奈克拉联合利妥昔单抗治疗慢性淋巴细胞白血病/小淋巴细胞淋巴瘤的疗效及安全性
Publicado: (2023)